Vimarsana
Biggest News Aggregation in the World

Study Arm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Arm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Arm Today - Breaking & Trending Today

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients - Vimarsana News

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

Published: May 29, 2024

Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response and two stable disease observations have occurred as of May 15,...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesPrehevbrio PrehevbriBrii BiosciencesDavide AndersonJeff BaxterCompany Quarterly Reports On FormAmerican Society Of Clinical OncologyVaccines IncOncology CenterDrug AdministrationClinical OncologyAnnual MeetingScientific OfficerFast TrackOrphan Drug DesignationsData Poster HighlightsStudy ArmGranulocyte Macrophage Colony Stimulating FactorRandomized PhaseCentral Nervous System TumorsPatient EnrollmentStudy DesignStudy Data HighlightsTrack Designation
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma - Vimarsana News

VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma

Published: April 3, 2024

Data highlighted in oral presentation at World Vaccine Congress 2024 on April 3, 2024 Early data from patients eligible for evaluation at week 12 show two observations of stable disease,...

Source: marketscreener.com
Related Topics:
United StatesUnited KingdomBrii BiosciencesDavide AndersonPrehevbrio PrehevbriCompany Quarterly Reports On FormDrug AdministrationOncology CenterVaccines IncWorld Vaccine Congress WashingtonScientific OfficerFast Track DesignationOrphan Drug DesignationData HighlightsStudy ArmGranulocyte Macrophage Colony Stimulating FactorPatient EnrollmentStudy Data HighlightsStudy DesignTrack DesignationAccelerated ApprovalPriority ReviewDrug EvaluationBiologics EvaluationClinical Trial Endpoints